临床肿瘤学杂志

• 综述与讲座 • 上一篇    下一篇

p44/WDR77基因在非小细胞肺癌中的研究进展

崔渊博 ,张志培,谷仲平   

  1. 710038 西安 第四军医大学唐都医院胸腔外科
  • 收稿日期:2015-05-01 修回日期:2015-06-22 出版日期:2015-11-30 发布日期:2015-11-30
  • 通讯作者: 谷仲平

Research progress of p44/WDR77 gene in non-small cell lung cancer

CUI Yuanbo, ZHANG Zhipei, GU Zhongping

  

  1. Department of Thoracic Surgery, Tangdu Hospital, the Forth Military Medical University, Xi'an 710038, China
  • Received:2015-05-01 Revised:2015-06-22 Online:2015-11-30 Published:2015-11-30
  • Contact: GU Zhongping

摘要:

肺癌死亡率居全球恶性肿瘤死亡之首,非小细胞肺癌(NSCLC)是肺癌中最常见类型,其发病机制尚未完全阐明。新近研究证实,雄激素受体辅助因子p44/WDR77基因表达是早期肺上皮细胞生长发育和NSCLC发生发展所必需的。p44/WDR77在NSCLC组织中的表达明显高于癌旁组织。抑制p44/WDR77表达使肺上皮细胞或NSCLC细胞阻滞于细胞周期的G1期,导致其停止生长,与p21-Rb-E2F信号通路有关。进一步在裸鼠肺癌模型体内抑制p44/WDR77表达,同样印证了NSCLC生长受到抑制。本研究将围绕p44/WDR77基因在NSCLC中的研究进展作一综述

Abstract:

Lung cancer is the leading cause of cancer deaths throughout the world. Non-small cell lung cancer (NSCLC) is the most common type of lung cancer. However, its pathogenesis has not been elucidated. Recently, researches have shown that p44/WDR77 expression is essential for the growth of lung epithelial cells and orthotropic lung adenocarcinoma tumors. The expression of 44-KDa androgen receptor cofactor/WD repeat domain 77 (p44/WDR77) gene in NSCLC is significantly higher than that in adjacent tissues. Loss of p44/WDR77 expression in lung epithelial cells and lung adenocarcinoma cancer cells leads to G1 cell cycle arrest via the p21-Rb-E2F signaling pathway. P44/WDR77 was re-expressed in lung cancer, and silencing p44/WDR77 expression strongly inhibited growth of lung adenocarcinoma tumor xenografts in mice. This article will briefly summarize the research progresses of p44/WDR77 in NSCLC.

No related articles found!
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!